Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug Administration (FDA) in the US — a relatively new process for novel devices which have not previously been classified.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.